Prevalence and Disease Spectrum of Extracoronary Arterial Abnormalities in Spontaneous Coronary Artery Dissection.


Journal

JAMA cardiology
ISSN: 2380-6591
Titre abrégé: JAMA Cardiol
Pays: United States
ID NLM: 101676033

Informations de publication

Date de publication:
01 02 2022
Historique:
pubmed: 25 11 2021
medline: 8 3 2022
entrez: 24 11 2021
Statut: ppublish

Résumé

Spontaneous coronary artery dissection (SCAD) has been associated with fibromuscular dysplasia (FMD) and other extracoronary arterial abnormalities. However, the prevalence, severity, and clinical relevance of these abnormalities remain unclear. To assess the prevalence and spectrum of FMD and other extracoronary arterial abnormalities in patients with SCAD vs controls. This case series included 173 patients with angiographically confirmed SCAD enrolled between January 1, 2015, and December 31, 2019. Imaging of extracoronary arterial beds was performed by magnetic resonance angiography (MRA). Forty-one healthy individuals were recruited to serve as controls for blinded interpretation of MRA findings. Patients were recruited from the UK national SCAD registry, which enrolls throughout the UK by referral from the primary care physician or patient self-referral through an online portal. Participants attended the national SCAD referral center for assessment and MRA. Both patients with SCAD and healthy controls underwent head-to-pelvis MRA (median time between SCAD event and MRA, 1 [IQR, 1-3] year). The diagnosis of FMD, arterial dissections, and aneurysms was established according to the International FMD Consensus. Arterial tortuosity was assessed both qualitatively (presence or absence of an S curve) and quantitatively (number of curves ≥45%; tortuosity index). Of the 173 patients with SCAD, 167 were women (96.5%); mean (SD) age at diagnosis was 44.5 (7.9) years. The prevalence of FMD was 31.8% (55 patients); 16 patients (29.1% of patients with FMD) had involvement of multiple vascular beds. Thirteen patients (7.5%) had extracoronary aneurysms and 3 patients (1.7%) had dissections. The prevalence and degree of arterial tortuosity were similar in patients and controls. In 43 patients imaged with both computed tomographic angiography and MRA, the identification of clinically significant remote arteriopathies was similar. Over a median 5-year follow-up, there were 2 noncardiovascular-associated deaths and 35 recurrent myocardial infarctions, but there were no primary extracoronary vascular events. In this case series with blinded analysis of patients with SCAD, severe multivessel FMD, aneurysms, and dissections were infrequent. The findings of this study suggest that, although brain-to-pelvis imaging allows detection of remote arteriopathies that may require follow-up, extracoronary vascular events appear to be rare.

Identifiants

pubmed: 34817541
pii: 2786555
doi: 10.1001/jamacardio.2021.4690
pmc: PMC8613702
doi:

Substances chimiques

Microfilament Proteins 0
PHACTR1 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

159-166

Subventions

Organisme : British Heart Foundation
ID : PG/13/96/30608
Pays : United Kingdom
Organisme : Department of Health
ID : CDF-2014-07-45
Pays : United Kingdom
Organisme : Department of Health
ID : RP-2017-08-ST2-007
Pays : United Kingdom

Auteurs

Alexandre Persu (A)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

Marilucy Lopez-Sublet (M)

Department of Internal Medicine, ESH Hypertension Excellence Centre, CHU Avicenne, AP-HP, Bobigny, France.
INSERM UMR 942 MASCOT, CHU Avicenne, AP-HP, Bobigny, France.

Abtehale Al-Hussaini (A)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Marco Pappaccogli (M)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.
Division of Internal Medicine and Hypertension Unit, Department of Medical Sciences, University of Turin, Turin, Italy.

Ibtissem Radhouani (I)

Department of Radiology, CHU Avicenne, AP-HP, UMR INSERM U1272, Université Sorbonne Paris Nord, Bobigny, France.

Patricia Van der Niepen (P)

Department of Nephrology & Hypertension, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

William Adair (W)

University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Christophe Beauloye (C)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

Pierre-Yves Brillet (PY)

Department of Radiology, CHU Avicenne, AP-HP, UMR INSERM U1272, Université Sorbonne Paris Nord, Bobigny, France.

Nathan Chan (N)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Patrick Chenu (P)

Division of Cardiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.
Pole of Cardiovascular Research, Institut de Recherche Expérimentale et Clinique, Université Catholique de Louvain, Brussels, Belgium.

Hannes Devos (H)

Department of Radiology, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Brussels, Belgium.

Javier Escaned (J)

Hospital Clínico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain.

Marcos Garcia-Guimaraes (M)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.
Department of Cardiology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.

Frank Hammer (F)

Division of Radiology, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium.

Robert Jackson (R)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Salma Jebri (S)

Department of Radiology, CHU Avicenne, AP-HP, UMR INSERM U1272, Université Sorbonne Paris Nord, Bobigny, France.

Deevia Kotecha (D)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Fernando Macaya (F)

Hospital Clínico San Carlos, IdISSC, Universidad Complutense, Madrid, Spain.

Ciara Mahon (C)

Royal Brompton and Harefield NHS Foundation Trust London, London, United Kingdom.

Nalin Natarajan (N)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Kandiyil Neghal (K)

University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Edward D Nicol (ED)

Royal Brompton and Harefield NHS Foundation Trust London, London, United Kingdom.
National Heart and Lung Institute, Imperial College, London, United Kingdom.

Kelly S Parke (KS)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Diluka Premawardhana (D)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Averachan Sajitha (A)

University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Joanne Wormleighton (J)

University Hospitals of Leicester, Glenfield Hospital, Leicester, United Kingdom.

Nilesh J Samani (NJ)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Gerry P McCann (GP)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

David Adlam (D)

Department of Cardiovascular Sciences, University of Leicester, NIHR Leicester Biomedical Research Centre, Glenfield Hospital, Leicester, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH